[Pharmaceutical characterization and spectroscopy of AWD 26-06].
To fix parameters for the pharmaceutical characterization of AWD 26-06 test methods converting identification, purity, content and stability as well as their results are submitted. Spectroscopic investigations are intended to give information on the constitution of the molecule.
Mayer
W
W
Geschäftsbereich Forschung und Entwicklung Arzneimittelwerk Dresden GmbH.
Usbeck
H
H
Dietz
G
G
Ohms
G
G
D000897:Anti-Ulcer Agents / Q000737:chemistry*; D002855:Chromatography, Thin Layer; D003984:Dibenzazepines / Q000737:chemistry*; D004355:Drug Stability; D008027:Light; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D013055:Spectrophotometry, Infrared; D013056:Spectrophotometry, Ultraviolet
D000897:Anti-Ulcer Agents; D003984:Dibenzazepines; C060713:AWD 26-06
Pharmazeutische Charakterisierung und Spektroskopie von AWD 26-06.